Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec announce OPTIZS initiative

I want to see every physician prioritizing the principle, "First, do no harm", by practicing in a sustainable way, says Barbara Erny

A recent clinical trial compares three cycles versus six cycles of CEV chemotherapy for high-risk retinoblastoma patients

Approaching the challenges of access and resources in Ghana’s health system

How physical activity and better sleep patterns can reduce the mental health impact of visual impairment

The Power List celebrates the world’s most inspiring and influential ophthalmologists

Shanghai-based researchers investigate three metabolite biomarkers for diagnosing and monitoring age-related macular degeneration

Could emerging neuroprotective strategies represent a new era for retinal disease treatment?

What’s a fair price for eye surgery?

The Ophthalmologist brings you the top news stories and studies of the week